Fiscal Year End Company Status Exempt Flag March 31 Trading N Board of Directors Name Position Alan Moore  Director of the Board Christina Yip  Secretary of the Board Chung Yu Wang  President Chung-Yu Wang  Director of the Board   Chairperson of the Board John Hsuan  Director of the Board Kevin McGarry  Director of the Board Telvin Ju  Director of the Board Tsong Chin Lin  Director of the Board Incorporation Locations Inc. Date Expiry Date Country Region Description 23/Apr/2004    Canada  British Columbia  Business Corporations Act  Exchange Filing Office Location Vancouver Regional Service Office		Business Type(s) Primary/Secondary Business Type Details Primary  Research and Development of Pharmaceutical Products  (not available)  Securities Symbol Security Name Market Status PBS Pacgen Life Science Corporation TSX Venture TRADING Name History From To Pacgen Life Science Corporation 1/May/2012 Present Company Facts Reconciliation Subject Date Returned Spring 2012 CFR Not Received Associations Auditing Firm:  Ernst & Young LLP Law Firm:  McCarthy Tetrault LLP Sponsor:  Jennings Capital Inc.   Canaccord Capital Corp. Subsidiary:  Xphase Pharmaceuticals Inc.   IL Therapeutics Inc. (100%) Transfer Agent:  Computershare Investor Services Inc.
Latest Information Type Date Title News Releases  9/May/2013  NEWS RELEASE - APPOINTS INTERIM CHIEF EXECUTIVE OFFICER[MARKET NEWS]     NEWS RELEASE - PACGEN APPOINTS INTERIM CHIEF EXECUTIVE OFFICER[MARKETWIRE]     NEWS RELEASE - TO EXHIBIT AT THE AMP 2012 ANNUAL MEETING IN LON[MARKET NEWS] Bulletins  30/Apr/2012  Name Change Meetings and Public Filings    Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations (not available)

* Historical Data